Cargando…
Tumor-penetrating nanoplatform with ultrasound “unlocking” for cascade synergistic therapy and visual feedback under hypoxia
BACKGROUND: Combined therapy based on the effects of cascade reactions of nanoplatforms to combat specific solid tumor microenvironments is considered a cancer treatment strategy with transformative clinical value. Unfortunately, an insufficient O(2) supply and the lack of a visual indication hinder...
Autores principales: | Xie, Zhuoyan, Wang, Junrui, Luo, Yuanli, Qiao, Bin, Jiang, Weixi, Zhu, Leilei, Ran, Haitao, Wang, Zhigang, Zhu, Wei, Ren, Jianli, Zhou, Zhiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878980/ https://www.ncbi.nlm.nih.gov/pubmed/36698190 http://dx.doi.org/10.1186/s12951-023-01765-x |
Ejemplares similares
-
TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy
por: Luo, Yuanli, et al.
Publicado: (2020) -
Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy
por: Jiang, Weixi, et al.
Publicado: (2022) -
Low Intensity Focused Ultrasound Ignited “Deep-Penetration Nanobomb” (DPNB) for Tetramodal Imaging Guided Hypoxia-Tolerant Sonodynamic Therapy Against Hypoxic Tumors
por: Luo, Yuanli, et al.
Publicado: (2022) -
Peptide Supramolecular Assembly‐Instructed In Situ Self‐Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens
por: Jiang, Weixi, et al.
Publicado: (2022) -
Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with PD-L1 blockade in reversing multidrug resistance
por: Jiang, Weixi, et al.
Publicado: (2021)